Mentions
Extended reach
Total likes
Video views
AI synopsis
Many discussions center on specific findings related to proteinuria and its association with kidney failure, illustrating a strong interest in the data's implications for patient care. Phrases like 'shocking high rates of kidney failure' and 'transformed our understanding' are used to convey heightened concern and excitement, reflecting how the tone elevates the urgency and seriousness of the study's findings.
Overall, the discussions reflect a consensus around the significance of the study's findings, with many expressing agreement on the importance of monitoring kidney function and protein levels.
There is high interest in the topic, as posts highlight the implications of the research for future treatments and management of IgA nephropathy.
While many posts simply share information, a subset engages deeply with the content, discussing specific studies like the RaDaR and asking questions about treatment goals.
The perception of the publication's impact is significant, with participants recognizing the urgent need for increased awareness and improved management strategies for IgA nephropathy.
En nefropatía por IgA, inclusive en los considerados de bajo riesgo de progresión (proteinuria <800mg y TFGe >30ml/min) la evolución renal es mala, el 30% necesita diálisis a 10 años La ↓proteinuria lo más asociado a bajar el riesgo CJASN 2023 DOI: 10.2215/CJN.0000000000000135 https://t.co/hLKk7MoZQL
Editor's Choice: Long-Term Outcomes in IgA Nephropathy This study found outcomes in a large IgA nephropathy cohort are generally poor with few patients expected to avoid kidney failure in their lifetime https://t.co/1cJlGYLso1 @IgAN_JBarratt @neilturn @Moinsaleem @DannyGale_1 https://t.co/ISWtCb8Alp
RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g/g (<100 mg/mmol), had high rates of kidney failure within 10 years ca. 2024 from @CJASN #Nephpearls #NephJC
RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g/g (<100 mg/mmol), had high rates of kidney failure within 10 years ca. 2024 from @CJASN #Nephpearls
IgA腎症の長期予後はタンパク尿1g/d以下だったとしても結構悪そうよ、という論文を読みました。 0.5-1g/gCrくらいのタンパク尿って、ステロイドなど免疫抑制かけるか悩ましい(だから腎生検も保留されがち)かもやけど、やっぱきちんと診断治療したほがよいかも
Proteinuria treatment goals
In this video, Prof. Dr. Jürgen Floege discusses established and innovative therapies for IgA nephropathy. Recent clinical trials reveal promising results for treatments like methylprednisolone, showing significant…
Dr. Daniel Gale emphasizes the critical role of rare kidney diseases in nephrology, highlighting data from the UK National Registry of Rare Kidney Diseases. This information underscores the urgency for early risk…
RT @autumnleaveskid: IgA腎症の長期予後はタンパク尿1g/d以下だったとしても結構悪そうよ、という論文を読みました。 0.5-1g/gCrくらいのタンパク尿って、ステロイドなど免疫抑制かけるか悩ましい(だから腎生検も保留されがち)かもやけど、やっぱきちんと…
RT @autumnleaveskid: IgA腎症の長期予後はタンパク尿1g/d以下だったとしても結構悪そうよ、という論文を読みました。 0.5-1g/gCrくらいのタンパク尿って、ステロイドなど免疫抑制かけるか悩ましい(だから腎生検も保留されがち)かもやけど、やっぱきちんと…
RT @autumnleaveskid: IgA腎症の長期予後はタンパク尿1g/d以下だったとしても結構悪そうよ、という論文を読みました。 0.5-1g/gCrくらいのタンパク尿って、ステロイドなど免疫抑制かけるか悩ましい(だから腎生検も保留されがち)かもやけど、やっぱきちんと…
RT @autumnleaveskid: IgA腎症の長期予後はタンパク尿1g/d以下だったとしても結構悪そうよ、という論文を読みました。 0.5-1g/gCrくらいのタンパク尿って、ステロイドなど免疫抑制かけるか悩ましい(だから腎生検も保留されがち)かもやけど、やっぱきちんと…
IgA腎症の長期予後はタンパク尿1g/d以下だったとしても結構悪そうよ、という論文を読みました。 0.5-1g/gCrくらいのタンパク尿って、ステロイドなど免疫抑制かけるか悩ましい(だから腎生検も保留されがち)かもやけど、やっぱきちんと診断治療したほがよいかも
RT @edgarvlermamd: Proteinuria treatment goals
RT @edgarvlermamd: Proteinuria treatment goals
RT @edgarvlermamd: Proteinuria treatment goals
RT @edgarvlermamd: Proteinuria treatment goals
RT @edgarvlermamd: Proteinuria treatment goals
RT @edgarvlermamd: Proteinuria treatment goals
RT @edgarvlermamd: Proteinuria treatment goals
Proteinuria treatment goals
The latest insights on IgA nephropathy highlight its progression from antibody buildup to kidney damage, with proteinuria as a key marker. Monitoring protein levels helps track disease severity. Read more: https://t.co/2TpXyrXagZ #PLSP #IgANephropathy https://t.co/tID10DOHcx
The latest research on IgA nephropathy explains how immune system antibodies damage the kidneys, leading to proteinuria and, in severe cases, kidney failure. Doctors track progression through urine protein tests. Read more: https://t.co/IRAnbwqUIi #PLSP #IgANephropathy https://t.co/C6SCljzHYK
RT @TravereMedical: Did you know? The UK National Registry of Rare Kidney Diseases Registry (RaDaR) has transformed our understanding of pr…
Did you know? The UK National Registry of Rare Kidney Diseases Registry (RaDaR) has transformed our understanding of proteinuria, eGFR slope and risk of kidney failure in IgA nephropathy. For more information on the RaDaR study click here: https://t.co/yWG5x0pgxB https://t.co/EjTH3C9bZ6
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
RT @n0r0zha: Are you aware of the long-term outcomes in IgA Nephropathy? #GlomConHawaii @GlomCon
RT @n0r0zha: Are you aware of the long-term outcomes in IgA Nephropathy? #GlomConHawaii @GlomCon
Are you aware of the long-term outcomes in IgA Nephropathy? #GlomConHawaii @GlomCon
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
Late to #NephJC but this RaDaR study has been on my radar lately #Nephpearls
Late to #NephJC but this RaDaR study has been on my radar lately #NephJC #Nephpearls
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g/g (<100 mg/mmol), had high rates of kidney failure within 10 years ca. 2024 from @CJASN #Nephpearls #NephJC
RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g/g (<100 mg/mmol), had high rates of kidney failure within 10 years ca. 2024 from @CJASN #Nephpearls #NephJC
RT @Tiff_Caza: @NephJC Another study with shockingly high rates of kidney failure in IgA nephropathy - >50% at follow-up. (maybe not shock…
@NephJC Another study with shockingly high rates of kidney failure in IgA nephropathy - >50% at follow-up. (maybe not shocking to the nephrologists, but surprised me) #NephJC https://t.co/RzpZA2RlOX
RT @edgarvlermamd: @dr_nikhilshah RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with prot…
RT @edgarvlermamd: @dr_nikhilshah RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with prot…
RT @edgarvlermamd: @dr_nikhilshah RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with prot…
RT @edgarvlermamd: @dr_nikhilshah RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with prot…
@dr_nikhilshah RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g/g (<100 mg/mmol), had high rates of kidney failure within 10 years ca. 2024 from @CJASN #Nephpearls
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
RT @edgarvlermamd: RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g…
RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g/g (<100 mg/mmol), had high rates of kidney failure within 10 years ca. 2024 from @CJASN #Nephpearls
RT @CJASN: Editor's Choice: Long-Term Outcomes in IgA Nephropathy This study found outcomes in a large IgA nephropathy cohort are generall…
RT @CJASN: Editor's Choice: Long-Term Outcomes in IgA Nephropathy This study found outcomes in a large IgA nephropathy cohort are generall…
RT @CJASN: Editor's Choice: Long-Term Outcomes in IgA Nephropathy This study found outcomes in a large IgA nephropathy cohort are generall…
RT @CJASN: Editor's Choice: Long-Term Outcomes in IgA Nephropathy This study found outcomes in a large IgA nephropathy cohort are generall…
RT @CJASN: Editor's Choice: Long-Term Outcomes in IgA Nephropathy This study found outcomes in a large IgA nephropathy cohort are generall…
RT @CJASN: Editor's Choice: Long-Term Outcomes in IgA Nephropathy This study found outcomes in a large IgA nephropathy cohort are generall…
RT @CJASN: Editor's Choice: Long-Term Outcomes in IgA Nephropathy This study found outcomes in a large IgA nephropathy cohort are generall…
RT @CJASN: Editor's Choice: Long-Term Outcomes in IgA Nephropathy This study found outcomes in a large IgA nephropathy cohort are generall…
RT @CJASN: Editor's Choice: Long-Term Outcomes in IgA Nephropathy This study found outcomes in a large IgA nephropathy cohort are generall…
RT @CJASN: Editor's Choice: Long-Term Outcomes in IgA Nephropathy This study found outcomes in a large IgA nephropathy cohort are generall…
RT @CJASN: Editor's Choice: Long-Term Outcomes in IgA Nephropathy This study found outcomes in a large IgA nephropathy cohort are generall…
RT @CJASN: Editor's Choice: Long-Term Outcomes in IgA Nephropathy This study found outcomes in a large IgA nephropathy cohort are generall…
RT @CJASN: Editor's Choice: Long-Term Outcomes in IgA Nephropathy This study found outcomes in a large IgA nephropathy cohort are generall…
RT @CJASN: Editor's Choice: Long-Term Outcomes in IgA Nephropathy This study found outcomes in a large IgA nephropathy cohort are generall…
RT @CJASN: Editor's Choice: Long-Term Outcomes in IgA Nephropathy This study found outcomes in a large IgA nephropathy cohort are generall…
RT @CJASN: Editor's Choice: Long-Term Outcomes in IgA Nephropathy This study found outcomes in a large IgA nephropathy cohort are generall…
RT @CJASN: Editor's Choice: Long-Term Outcomes in IgA Nephropathy This study found outcomes in a large IgA nephropathy cohort are generall…
RT @CJASN: Editor's Choice: Long-Term Outcomes in IgA Nephropathy This study found outcomes in a large IgA nephropathy cohort are generall…
RT @CJASN: Editor's Choice: Long-Term Outcomes in IgA Nephropathy This study found outcomes in a large IgA nephropathy cohort are generall…
RT @CJASN: Editor's Choice: Long-Term Outcomes in IgA Nephropathy This study found outcomes in a large IgA nephropathy cohort are generall…
RT @CJASN: Editor's Choice: Long-Term Outcomes in IgA Nephropathy This study found outcomes in a large IgA nephropathy cohort are generall…
RT @CJASN: Editor's Choice: Long-Term Outcomes in IgA Nephropathy This study found outcomes in a large IgA nephropathy cohort are generall…
RT @CJASN: Editor's Choice: Long-Term Outcomes in IgA Nephropathy This study found outcomes in a large IgA nephropathy cohort are generall…
RT @CJASN: Editor's Choice: Long-Term Outcomes in IgA Nephropathy This study found outcomes in a large IgA nephropathy cohort are generall…
RT @CJASN: Editor's Choice: Long-Term Outcomes in IgA Nephropathy This study found outcomes in a large IgA nephropathy cohort are generall…
RT @CJASN: Editor's Choice: Long-Term Outcomes in IgA Nephropathy This study found outcomes in a large IgA nephropathy cohort are generall…
RT @CJASN: Editor's Choice: Long-Term Outcomes in IgA Nephropathy This study found outcomes in a large IgA nephropathy cohort are generall…
Editor's Choice: Long-Term Outcomes in IgA Nephropathy This study found outcomes in a large IgA nephropathy cohort are generally poor with few patients expected to avoid kidney failure in their lifetime https://t.co/1cJlGYLso1 @IgAN_JBarratt @neilturn @Moinsaleem @DannyGale_1 https://t.co/ISWtCb8Alp
Long-Term Outcomes in IgA Nephropathy : Clinical Journal of the American Society of Nephrology https://t.co/j4kPbdxBXu
Long-Term Outcomes in IgA Nephropathy : Clinical Journal of the American Society of Nephrology https://t.co/Oqk37OjaRF Patients traditionally regarded as being low risk, with proteinuria <0.88 g/g (<100 mg/mmol), had high rates of kidney failure within 10 years.
Long-Term Outcomes in IgA Nephropathy https://t.co/vWckiZ0czd
15a) To finish we had new data presented from the UK #RaDaR #IgAN cohort. (See
RT @M_Elraggal: Long-Term Outcomes in IgA Nephropathy : Clinical Journal of the American Society of Nephrology https://t.co/J1M6XnHPDu
Long-Term Outcomes in IgA Nephropathy : Clinical Journal of the American Society of Nephrology https://t.co/uWWwRVCPQD
RT @M_Elraggal: Long-Term Outcomes in IgA Nephropathy : Clinical Journal of the American Society of Nephrology https://t.co/J1M6XnHPDu
Long-Term Outcomes in IgA Nephropathy : Clinical Journal of the American Society of Nephrology https://t.co/J1M6XnHPDu
RT @RenalRadar: More RaDaR Research: Long term outcomes in IgA nephropathy (Pitcher et al Clinical Journal of the American Society of Nephr…
More RaDaR Research: Long term outcomes in IgA nephropathy (Pitcher et al Clinical Journal of the American Society of Nephrology, 2023; https://t.co/WLHQbudkQq
RT @JonathanNefro: En nefropatía por IgA, inclusive en los considerados de bajo riesgo de progresión (proteinuria <800mg y TFGe >30ml/min)…
RT @CmnoNefrologia:
Open Access UCL Research: Long-Term Outcomes in IgA Nephropathy https://t.co/Y4dcrGExf9
RT @JonathanNefro: En nefropatía por IgA, inclusive en los considerados de bajo riesgo de progresión (proteinuria <800mg y TFGe >30ml/min)…
RT @JonathanNefro: En nefropatía por IgA, inclusive en los considerados de bajo riesgo de progresión (proteinuria <800mg y TFGe >30ml/min)…
RT @JonathanNefro: En nefropatía por IgA, inclusive en los considerados de bajo riesgo de progresión (proteinuria <800mg y TFGe >30ml/min)…
RT @JonathanNefro: En nefropatía por IgA, inclusive en los considerados de bajo riesgo de progresión (proteinuria <800mg y TFGe >30ml/min)…
RT @JonathanNefro: En nefropatía por IgA, inclusive en los considerados de bajo riesgo de progresión (proteinuria <800mg y TFGe >30ml/min)…
RT @JonathanNefro: En nefropatía por IgA, inclusive en los considerados de bajo riesgo de progresión (proteinuria <800mg y TFGe >30ml/min)…
RT @JonathanNefro: En nefropatía por IgA, inclusive en los considerados de bajo riesgo de progresión (proteinuria <800mg y TFGe >30ml/min)…
RT @JonathanNefro: En nefropatía por IgA, inclusive en los considerados de bajo riesgo de progresión (proteinuria <800mg y TFGe >30ml/min)…
RT @JonathanNefro: En nefropatía por IgA, inclusive en los considerados de bajo riesgo de progresión (proteinuria <800mg y TFGe >30ml/min)…
RT @JonathanNefro: En nefropatía por IgA, inclusive en los considerados de bajo riesgo de progresión (proteinuria <800mg y TFGe >30ml/min)…
RT @JonathanNefro: En nefropatía por IgA, inclusive en los considerados de bajo riesgo de progresión (proteinuria <800mg y TFGe >30ml/min)…
RT @JonathanNefro: En nefropatía por IgA, inclusive en los considerados de bajo riesgo de progresión (proteinuria <800mg y TFGe >30ml/min)…
RT @JonathanNefro: En nefropatía por IgA, inclusive en los considerados de bajo riesgo de progresión (proteinuria <800mg y TFGe >30ml/min)…
RT @JonathanNefro: En nefropatía por IgA, inclusive en los considerados de bajo riesgo de progresión (proteinuria <800mg y TFGe >30ml/min)…
RT @JonathanNefro: En nefropatía por IgA, inclusive en los considerados de bajo riesgo de progresión (proteinuria <800mg y TFGe >30ml/min)…
RT @JonathanNefro: En nefropatía por IgA, inclusive en los considerados de bajo riesgo de progresión (proteinuria <800mg y TFGe >30ml/min)…
En nefropatía por IgA, inclusive en los considerados de bajo riesgo de progresión (proteinuria <800mg y TFGe >30ml/min) la evolución renal es mala, el 30% necesita diálisis a 10 años La ↓proteinuria lo más asociado a bajar el riesgo CJASN 2023 DOI: 10.2215/CJN.0000000000000135 https://t.co/hLKk7MoZQL
RT @ASPNeph: Long-Term Outcomes in #IgA_Nephropathy https://t.co/I2gvxux5Q2 @CJASN
RT @ASPNeph: Long-Term Outcomes in #IgA_Nephropathy https://t.co/I2gvxux5Q2 @CJASN
RT @ASPNeph: Long-Term Outcomes in #IgA_Nephropathy https://t.co/I2gvxux5Q2 @CJASN
Long-Term Outcomes in #IgA_Nephropathy https://t.co/I2gvxux5Q2 @CJASN
Long-Term Outcomes in IgA Nephropathy. Journal: https://t.co/yaBNvgYfaF #clinicalclub #Nephrotube https://t.co/Wbypa0hXPb
RT @cravedilab: Long-Term Outcomes in IgA Nephropathy : Clinical Journal of the American Society of Nephrology https://t.co/bk2nuPEsE4
RT @cravedilab: Long-Term Outcomes in IgA Nephropathy : Clinical Journal of the American Society of Nephrology https://t.co/bk2nuPEsE4
RT @cravedilab: Long-Term Outcomes in IgA Nephropathy : Clinical Journal of the American Society of Nephrology https://t.co/bk2nuPEsE4
RT @cravedilab: Long-Term Outcomes in IgA Nephropathy : Clinical Journal of the American Society of Nephrology https://t.co/bk2nuPEsE4
RT @cravedilab: Long-Term Outcomes in IgA Nephropathy : Clinical Journal of the American Society of Nephrology https://t.co/bk2nuPEsE4
RT @cravedilab: Long-Term Outcomes in IgA Nephropathy : Clinical Journal of the American Society of Nephrology https://t.co/bk2nuPEsE4
RT @cravedilab: Long-Term Outcomes in IgA Nephropathy : Clinical Journal of the American Society of Nephrology https://t.co/bk2nuPEsE4
RT @cravedilab: Long-Term Outcomes in IgA Nephropathy : Clinical Journal of the American Society of Nephrology https://t.co/bk2nuPEsE4
Long-Term Outcomes in IgA Nephropathy : Clinical Journal of the American Society of Nephrology https://t.co/bk2nuPEsE4